Sunshine Biopharma, Inc. (SBFM)

USD 2.75

(0.37%)

Revenue Summary of Sunshine Biopharma, Inc.

  • Sunshine Biopharma, Inc.'s latest annual revenue in 2023 was 24.09 Million USD , up 454.42% from previous year.
  • Sunshine Biopharma, Inc.'s latest quarterly revenue in 2024 Q2 was 9.3 Million USD , up 23.37% from previous quarter.
  • Sunshine Biopharma, Inc. reported a annual revenue of 4.34 Million USD in annual revenue 2022, up 1802.41% from previous year.
  • Sunshine Biopharma, Inc. reported a annual revenue of 228.42 Thousand USD in annual revenue 2021, up 219.88% from previous year.
  • Sunshine Biopharma, Inc. reported a quarterly revenue of 7.54 Million USD for 2024 Q1, down -1.81% from previous quarter.
  • Sunshine Biopharma, Inc. reported a quarterly revenue of 5.95 Million USD for 2023 Q3, up 7.14% from previous quarter.

Annual Revenue Chart of Sunshine Biopharma, Inc. (2023 - 2007)

Historical Annual Revenue of Sunshine Biopharma, Inc. (2023 - 2007)

Year Revenue Revenue Growth
2023 24.09 Million USD 454.42%
2022 4.34 Million USD 1802.41%
2021 228.42 Thousand USD 219.88%
2020 71.41 Thousand USD 238.1%
2019 21.12 Thousand USD -95.28%
2018 447.2 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 1708.00 USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%

Peer Revenue Comparison of Sunshine Biopharma, Inc.

Name Revenue Revenue Difference
Theratechnologies Inc. 81.76 Million USD 70.534%
Harrow Health, Inc. 130.19 Million USD 81.495%
Dynavax Technologies Corporation 232.28 Million USD 89.628%
Biofrontera Inc. 34.07 Million USD 29.287%
Cronos Group Inc. 88.84 Million USD 72.881%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -89.186%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 94.558%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -269.909%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 39.087%
Radius Health, Inc. 2.88 Billion USD 99.164%
Universe Pharmaceuticals INC 32.3 Million USD 25.429%
DURECT Corporation 8.54 Million USD -181.853%
ProPhase Labs, Inc. 44.38 Million USD 45.717%
Safety Shot Inc 202.67 Thousand USD -11787.693%
Phibro Animal Health Corporation 1.01 Billion USD 97.633%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -1149.304%
Alvotech 91.43 Million USD 73.65%
Assertio Holdings, Inc. 152.06 Million USD 84.157%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 96.034%
Rockwell Medical, Inc. 83.61 Million USD 71.185%
Procaps Group S.A. 409.92 Million USD 94.123%
Intra-Cellular Therapies, Inc. 464.37 Million USD 94.812%
SCYNEXIS, Inc. 140.14 Million USD 82.808%
Aytu BioPharma, Inc. 81 Million USD 70.257%
Viatris Inc. 15.42 Billion USD 99.844%
OptiNose, Inc. 70.98 Million USD 66.06%
SIGA Technologies, Inc. 139.91 Million USD 82.781%
Tilray Brands, Inc. 788.94 Million USD 96.946%
PetIQ, Inc. 1.1 Billion USD 97.814%
Sunshine Biopharma, Inc. 24.09 Million USD 0.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 98.723%
Guardion Health Sciences, Inc. 12.24 Million USD -96.699%
Alimera Sciences, Inc. 80.75 Million USD 70.165%
Collegium Pharmaceutical, Inc. 566.76 Million USD 95.749%
Silver Spike Investment Corp. 11.72 Million USD -105.532%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Organogenesis Holdings Inc. 433.14 Million USD 94.438%
Journey Medical Corporation 79.18 Million USD 69.573%
Petros Pharmaceuticals, Inc. 5.82 Million USD -313.796%
Alpha Teknova, Inc. 36.68 Million USD 34.323%
Clever Leaves Holdings Inc. 17.41 Million USD -38.329%
Lifecore Biomedical, Inc. 128.26 Million USD 81.216%
PainReform Ltd. - USD -Infinity%
Cosmos Health Inc. 53.37 Million USD 54.863%
Avadel Pharmaceuticals plc 27.96 Million USD 13.84%
TherapeuticsMD, Inc. 1.3 Million USD -1750.444%
Embecta Corp. 1.12 Billion USD 97.85%
Regencell Bioscience Holdings Limited - USD -Infinity%
Talphera, Inc. 651 Thousand USD -3600.889%
Pacira BioSciences, Inc. 674.97 Million USD 96.431%
Incannex Healthcare Limited 12 Thousand USD -200673.225%
Cyclo Therapeutics, Inc. 1.07 Million USD -2138.264%
Shineco, Inc. 9.8 Million USD -145.798%
Procaps Group, S.A. 409.92 Million USD 94.123%
ANI Pharmaceuticals, Inc. 486.81 Million USD 95.051%
Aquestive Therapeutics, Inc. 50.58 Million USD 52.37%
Lantheus Holdings, Inc. 1.29 Billion USD 98.142%
Alvotech 91.43 Million USD 73.65%
Hempacco Co., Inc. 4.04 Million USD -495.525%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 92.39%
Bright Green Corporation 401.49 Thousand USD -5900.829%
Esperion Therapeutics, Inc. 116.33 Million USD 79.29%
Kamada Ltd. 144.75 Million USD 83.357%
Indivior PLC 1.09 Billion USD 97.796%
Evoke Pharma, Inc. 5.18 Million USD -365.055%
Flora Growth Corp. 76.07 Million USD 68.329%
Cyclo Therapeutics, Inc. 1.07 Million USD -2138.264%
Evolus, Inc. 202.08 Million USD 88.078%
HUTCHMED (China) Limited 837.99 Million USD 97.125%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 96.261%
Akanda Corp. 2.16 Million USD -1015.38%